In 1994, a group from Myriad and their collaborators announced that they located a strong candidate for BRCA1. Their patent on this gene was granted in 1997. Although they were not the first to find the second breast cancer gene (BRCA2), Myriad was the first to isolate it. They patented BRCA2 in 2001.
breast cancer gene,brca 1,breast cancer,collaborators,patent